Cargando…
The Bacterial Genomic Context of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases Highlights an Emerging Threat to Public Health
Type B dihydrofolate reductase (dfrb) genes were identified following the introduction of trimethoprim in the 1960s. Although they intrinsically confer resistance to trimethoprim (TMP) that is orders of magnitude greater than through other mechanisms, the distribution and prevalence of these short (...
Autores principales: | Lemay-St-Denis, Claudèle, Diwan, Sarah-Slim, Pelletier, Joelle N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103504/ https://www.ncbi.nlm.nih.gov/pubmed/33924456 http://dx.doi.org/10.3390/antibiotics10040433 |
Ejemplares similares
-
Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance
por: Cellier-Goetghebeur, Stella, et al.
Publicado: (2022) -
Trimethoprim resistance in surface and wastewater is mediated by contrasting variants of the dfrB gene
por: Kneis, David, et al.
Publicado: (2023) -
Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors
por: Wróbel, Agnieszka, et al.
Publicado: (2019) -
Structure-Based Design of Dimeric Bisbenzimidazole
Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate
Reductase Guides the Design of Monomeric Analogues
por: Toulouse, Jacynthe L., et al.
Publicado: (2019) -
Characterization of trimethoprim resistant E. coli dihydrofolate reductase mutants by mass spectrometry and inhibition by propargyl-linked antifolates
por: Cammarata, Michael, et al.
Publicado: (2017)